首页 > 最新文献

Japanese Journal of Ophthalmology最新文献

英文 中文
Improvements in visual function early after cataract surgery in eyes implanted with multifocal intraocular lenses. 植入多焦人工晶体的眼睛在白内障手术后早期视觉功能的改善。
IF 2.1 3区 医学 Q2 OPHTHALMOLOGY Pub Date : 2025-01-01 Epub Date: 2024-10-21 DOI: 10.1007/s10384-024-01130-x
Ken Hayashi, Motoaki Yoshida, Shin-Ichi Manabe, Akira Hirata

Purpose: To compare the improvements in all-distance visual acuity (VA) and contrast sensitivity early after cataract surgery among eyes implanted with multifocal and monofocal intraocular lenses (IOLs).

Study design: Nonrandomized comparative study.

Methods: Forty-two eyes with a trifocal IOL (Alcon, PanOptix®), 42 eyes with a combined bifocal and extended-depth-of-focus (EDF) IOL (Johnson & Johnson, Synergy®), and 84 eyes with a monofocal IOL were recruited. Uncorrected or corrected VA at various distances, and photopia and mesopic contrast VA were examined at 1 day and 3 months postoperatively. Improvements in these VAs were compared between time points and among groups.

Results: Mean uncorrected as well as corrected VA improved significantly between 1 day and 3 months postoperatively at almost all distances in the trifocal and combined bifocal + EDF groups (P ≤ 0.018), and at the intermediate distance of 1.0 m and far distances in the monofocal group (P ≤ 0.031). Mean improvements in near uncorrected VA at 0.3 m, intermediate VA at 0.5 m, and far VA at 2.0, 3.0, and 5.0 m were significantly greater in the multifocal groups than in the monofocal group (P ≤ 0.032). Improvements in photopic and mesopic contrast VA at most contrasts were significantly better in the multifocal groups (P ≤ 0.021).

Conclusion: Mean uncorrected or corrected VA at almost all distances and contrast sensitivity at most contrasts improved significantly early after surgery in eyes implanted with multifocal IOLs, and the improvements in VA at most distances and in contrast sensitivity were better with multifocal IOLs than with monofocal IOLs.

目的:比较植入多焦点和单焦点人工晶体(IOL)的眼睛在白内障手术后早期远距离视力(VA)和对比敏感度的改善情况:研究设计:非随机对比研究:招募了 42 只植入三焦点人工晶体(爱尔康,PanOptix®)的眼睛、42 只植入双焦点和延伸焦深(EDF)联合人工晶体(强生,Synergy®)的眼睛以及 84 只植入单焦点人工晶体的眼睛。在术后 1 天和 3 个月检查了各种距离的未校正或校正视力,以及光视和中视对比视力。结果:结果:在术后 1 天和 3 个月期间,三焦点组和联合双焦点 + EDF 组在几乎所有距离上的平均未校正视力和校正视力都有显著改善(P ≤ 0.018),单焦点组在 1.0 米的中距离和远距离上的平均未校正视力和校正视力都有显著改善(P ≤ 0.031)。多焦点组在 0.3 米处的近距离未校正视力、0.5 米处的中距离视力以及 2.0、3.0 和 5.0 米处的远距离视力的平均改善程度显著高于单焦点组(P ≤ 0.032)。在大多数对比度下,多焦点组的光感和中感对比视力改善明显更好(P ≤ 0.021):结论:植入多焦点人工晶体的眼睛在术后早期,几乎所有距离的平均未矫正或矫正视力和大多数对比度的对比敏感度都有明显改善,多焦点人工晶体对大多数距离的视力和对比敏感度的改善效果优于单焦点人工晶体。
{"title":"Improvements in visual function early after cataract surgery in eyes implanted with multifocal intraocular lenses.","authors":"Ken Hayashi, Motoaki Yoshida, Shin-Ichi Manabe, Akira Hirata","doi":"10.1007/s10384-024-01130-x","DOIUrl":"10.1007/s10384-024-01130-x","url":null,"abstract":"<p><strong>Purpose: </strong>To compare the improvements in all-distance visual acuity (VA) and contrast sensitivity early after cataract surgery among eyes implanted with multifocal and monofocal intraocular lenses (IOLs).</p><p><strong>Study design: </strong>Nonrandomized comparative study.</p><p><strong>Methods: </strong>Forty-two eyes with a trifocal IOL (Alcon, PanOptix<sup>®</sup>), 42 eyes with a combined bifocal and extended-depth-of-focus (EDF) IOL (Johnson & Johnson, Synergy<sup>®</sup>), and 84 eyes with a monofocal IOL were recruited. Uncorrected or corrected VA at various distances, and photopia and mesopic contrast VA were examined at 1 day and 3 months postoperatively. Improvements in these VAs were compared between time points and among groups.</p><p><strong>Results: </strong>Mean uncorrected as well as corrected VA improved significantly between 1 day and 3 months postoperatively at almost all distances in the trifocal and combined bifocal + EDF groups (P ≤ 0.018), and at the intermediate distance of 1.0 m and far distances in the monofocal group (P ≤ 0.031). Mean improvements in near uncorrected VA at 0.3 m, intermediate VA at 0.5 m, and far VA at 2.0, 3.0, and 5.0 m were significantly greater in the multifocal groups than in the monofocal group (P ≤ 0.032). Improvements in photopic and mesopic contrast VA at most contrasts were significantly better in the multifocal groups (P ≤ 0.021).</p><p><strong>Conclusion: </strong>Mean uncorrected or corrected VA at almost all distances and contrast sensitivity at most contrasts improved significantly early after surgery in eyes implanted with multifocal IOLs, and the improvements in VA at most distances and in contrast sensitivity were better with multifocal IOLs than with monofocal IOLs.</p>","PeriodicalId":14563,"journal":{"name":"Japanese Journal of Ophthalmology","volume":" ","pages":"32-42"},"PeriodicalIF":2.1,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142465583","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retinal detachment after acute retinal necrosis: a retrospective analysis of hospitalized patients. 急性视网膜坏死后视网膜脱离:住院患者的回顾性分析。
IF 2.1 3区 医学 Q2 OPHTHALMOLOGY Pub Date : 2025-01-01 Epub Date: 2025-01-18 DOI: 10.1007/s10384-024-01148-1
Suk Hoon Jung, Sang Un Yi, Young-Hoon Park

Purpose: To review hospitalized patients with Acute Retinal Necrosis (ARN) and investigate factors associated with subsequent retinal detachment (RD).

Study design: Retrospective.

Methods: The study included 40 patients (42 eyes), categorized into non-RD (23 eyes) and RD (19 eyes) groups. Patient demographics, ocular findings, treatment history, and visual outcomes were analyzed.

Results: The RD group had higher diabetes prevalence and worse initial and final visual acuity (VA) than the non-RD group (p = 0.035, p = 0.001, p = 0.000). The extent of retinal involvement was greater in the RD group (p = 0.000). The total steroid dose up to RD was significantly lower in the RD group (p = 0.023). Worse initial VA (p = 0.035) and greater retinal involvement (p = 0.036) increased the risk of RD. In the RD group, the time from initial symptoms to RD positively correlated with the duration of oral antivirals, the number of intravitreal antiviral injections, and the duration of oral steroids and immunosuppressants (p = 0.000, p = 0.023, p = 0.018, p = 0.001). The use of oral antivirals, steroids, and immunosuppressants was associated with longer median survival times compared to non-use (p = 0.000, p = 0.000, p = 0.048). The group receiving 9-11 intravitreal antiviral injections had a longer median survival time than the 0-4 and 5-8 injection groups (p = 0.009, p = 0.032).

Conclusions: In ARN, reduced steroid use due to diabetes may be associated with RD through inflammatory changes. The worse the initial VA and the greater the extent of retinal lesions, the higher the risk of RD. Oral antivirals, intravitreal antiviral injections, oral steroids, and oral immunosuppressants may be effective in delaying RD.

目的:回顾急性视网膜坏死(ARN)住院患者并探讨继发视网膜脱离(RD)的相关因素。研究设计:回顾性。方法:选取40例患者(42眼),分为非RD组(23眼)和RD组(19眼)。分析患者人口统计学、眼部表现、治疗史和视力结果。结果:RD组糖尿病患病率高于非RD组,初始和最终视力(VA)差(p = 0.035, p = 0.001, p = 0.000)。RD组视网膜受累程度更大(p = 0.000)。RD组的总类固醇剂量显著低于RD组(p = 0.023)。较差的初始VA (p = 0.035)和较大的视网膜受累(p = 0.036)增加了RD的风险。在RD组中,从初始症状到RD的时间与口服抗病毒药物的持续时间、玻璃体内抗病毒药物注射的次数以及口服类固醇和免疫抑制剂的持续时间呈正相关(p = 0.000, p = 0.023, p = 0.018, p = 0.001)。使用口服抗病毒药物、类固醇和免疫抑制剂与不使用相比,中位生存时间更长(p = 0.000, p = 0.000, p = 0.048)。注射9 ~ 11次玻璃体内抗病毒药物组的中位生存时间较注射0 ~ 4次和5 ~ 8次组长(p = 0.009, p = 0.032)。结论:在ARN中,糖尿病导致的类固醇使用减少可能通过炎症改变与RD相关。初始VA越严重,视网膜病变程度越大,RD的风险越高。口服抗病毒药物、玻璃体内抗病毒药物注射、口服类固醇和口服免疫抑制剂可能对延迟RD有效。
{"title":"Retinal detachment after acute retinal necrosis: a retrospective analysis of hospitalized patients.","authors":"Suk Hoon Jung, Sang Un Yi, Young-Hoon Park","doi":"10.1007/s10384-024-01148-1","DOIUrl":"10.1007/s10384-024-01148-1","url":null,"abstract":"<p><strong>Purpose: </strong>To review hospitalized patients with Acute Retinal Necrosis (ARN) and investigate factors associated with subsequent retinal detachment (RD).</p><p><strong>Study design: </strong>Retrospective.</p><p><strong>Methods: </strong>The study included 40 patients (42 eyes), categorized into non-RD (23 eyes) and RD (19 eyes) groups. Patient demographics, ocular findings, treatment history, and visual outcomes were analyzed.</p><p><strong>Results: </strong>The RD group had higher diabetes prevalence and worse initial and final visual acuity (VA) than the non-RD group (p = 0.035, p = 0.001, p = 0.000). The extent of retinal involvement was greater in the RD group (p = 0.000). The total steroid dose up to RD was significantly lower in the RD group (p = 0.023). Worse initial VA (p = 0.035) and greater retinal involvement (p = 0.036) increased the risk of RD. In the RD group, the time from initial symptoms to RD positively correlated with the duration of oral antivirals, the number of intravitreal antiviral injections, and the duration of oral steroids and immunosuppressants (p = 0.000, p = 0.023, p = 0.018, p = 0.001). The use of oral antivirals, steroids, and immunosuppressants was associated with longer median survival times compared to non-use (p = 0.000, p = 0.000, p = 0.048). The group receiving 9-11 intravitreal antiviral injections had a longer median survival time than the 0-4 and 5-8 injection groups (p = 0.009, p = 0.032).</p><p><strong>Conclusions: </strong>In ARN, reduced steroid use due to diabetes may be associated with RD through inflammatory changes. The worse the initial VA and the greater the extent of retinal lesions, the higher the risk of RD. Oral antivirals, intravitreal antiviral injections, oral steroids, and oral immunosuppressants may be effective in delaying RD.</p>","PeriodicalId":14563,"journal":{"name":"Japanese Journal of Ophthalmology","volume":" ","pages":"131-138"},"PeriodicalIF":2.1,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143005468","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparisons of oscillatory potentials and 30 Hz flicker electroretinograms for discriminating eyes with diabetic retinopathy from normal eyes.
IF 2.1 3区 医学 Q2 OPHTHALMOLOGY Pub Date : 2025-01-01 Epub Date: 2025-01-30 DOI: 10.1007/s10384-024-01154-3
Mana Gonmori, Shigeki Machida, Shinya Inoue, Satoshi Ebihara, Keita Misu

Purpose: To compare the amplitudes and implicit times of the oscillatory (OPs) of the full-field electroretinograms (ERGs) to those of the 30 Hz flicker ERGs in differentiating eyes with diabetic retinopathy (DR) from normal eyes.

Study design: Single-center observational study.

Methods: Full-field ERGs were recorded in 55 patients with Type 2 diabetes mellitus (DM) and 20 normal control subjects. The amplitudes and implicit times of the OPs and of the 30 Hz flicker ERGs were measured. Optical coherence tomography angiography (OCTA) was used to record 3×3 mm enface images of the retina from which the vascular density (VD) of the superficial capillary plexus (SCP) and deep capillary plexus (DCP) were obtained. The receiver operating characteristic (ROC) curves were used to determine the ability of each ERG parameter to discriminate diseased eyes from normal eyes. The significance of the correlations between each ERG parameter and the VD of the SCP and DCP was determined.

Results: The area under the ROC curves (AUCs) was significantly larger for the implicit times than for the amplitudes of each ERG component (P<0.005). There were no significant differences in the AUCs between the OPs and 30 Hz flicker ERGs in differentiating eyes with DM or DR from normal eyes. The implicit time of the 30 Hz flicker ERG had the highest significant correlation coefficient with the VD of the DCP (r = - 0.31, P <0.001).

Conclusions: The OPs and 30 Hz flicker ERGs have equal ability in differentiating eyes with DR from normal eyes but with better ability for the implicit times than the amplitudes. The implicit time of the 30 Hz flicker ERG is the most sensitive parameter that is correlated with the reduction of VD among the full-field ERG components.

{"title":"Comparisons of oscillatory potentials and 30 Hz flicker electroretinograms for discriminating eyes with diabetic retinopathy from normal eyes.","authors":"Mana Gonmori, Shigeki Machida, Shinya Inoue, Satoshi Ebihara, Keita Misu","doi":"10.1007/s10384-024-01154-3","DOIUrl":"10.1007/s10384-024-01154-3","url":null,"abstract":"<p><strong>Purpose: </strong>To compare the amplitudes and implicit times of the oscillatory (OPs) of the full-field electroretinograms (ERGs) to those of the 30 Hz flicker ERGs in differentiating eyes with diabetic retinopathy (DR) from normal eyes.</p><p><strong>Study design: </strong>Single-center observational study.</p><p><strong>Methods: </strong>Full-field ERGs were recorded in 55 patients with Type 2 diabetes mellitus (DM) and 20 normal control subjects. The amplitudes and implicit times of the OPs and of the 30 Hz flicker ERGs were measured. Optical coherence tomography angiography (OCTA) was used to record 3×3 mm enface images of the retina from which the vascular density (VD) of the superficial capillary plexus (SCP) and deep capillary plexus (DCP) were obtained. The receiver operating characteristic (ROC) curves were used to determine the ability of each ERG parameter to discriminate diseased eyes from normal eyes. The significance of the correlations between each ERG parameter and the VD of the SCP and DCP was determined.</p><p><strong>Results: </strong>The area under the ROC curves (AUCs) was significantly larger for the implicit times than for the amplitudes of each ERG component (P<0.005). There were no significant differences in the AUCs between the OPs and 30 Hz flicker ERGs in differentiating eyes with DM or DR from normal eyes. The implicit time of the 30 Hz flicker ERG had the highest significant correlation coefficient with the VD of the DCP (r = - 0.31, P <0.001).</p><p><strong>Conclusions: </strong>The OPs and 30 Hz flicker ERGs have equal ability in differentiating eyes with DR from normal eyes but with better ability for the implicit times than the amplitudes. The implicit time of the 30 Hz flicker ERG is the most sensitive parameter that is correlated with the reduction of VD among the full-field ERG components.</p>","PeriodicalId":14563,"journal":{"name":"Japanese Journal of Ophthalmology","volume":" ","pages":"49-58"},"PeriodicalIF":2.1,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143065564","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Choroidal thickness in macular, nasal midperiphery, and temporal midperiphery regions and its relationship with axial length and refractive error. 黄斑、鼻中周和颞中周区域的脉络膜厚度及其与轴长和屈光不正的关系。
IF 2.1 3区 医学 Q2 OPHTHALMOLOGY Pub Date : 2025-01-01 Epub Date: 2024-11-02 DOI: 10.1007/s10384-024-01128-5
Takahiro Hiraoka, Masato Tamura, Toshihiro Mino, Yoshikiyo Moriguchi, Masahiro Akiba, Yoshimi Sugiura, Toshifumi Mihashi, Tetsuro Oshika

Purpose: This study aimed to investigate the choroidal thickness (ChT) distribution in adult myopic eyes, focusing on the macular, nasal midperiphery, and temporal midperiphery regions, and to explore its relationship with axial length (AL) and refractive error.

Study design: A cross-sectional, observational study.

Methods: Twenty-nine eyes of 29 adult volunteers were examined. ChT was measured using high-speed swept-source optical coherence tomography covering an area of 50 degrees in three different regions: centered at macular, nasal side at 33 degrees, and temporal side at 33 degrees. Statistical analyses were performed to assess differences in ChT between regions and correlations with AL and spherical equivalent (SE).

Results: ChT was found to be thickest in the macular region, followed by the nasal and temporal midperiphery regions. Significant correlations were observed between AL/SE and ChT in the macular and temporal regions, but not in the nasal region. The temporal midperiphery showed the strongest correlation with AL and SE.

Conclusion: This study revealed a nasal-temporal asymmetry in ChT distribution in myopic eyes, with the temporal midperiphery showing the thinnest ChT. The strong correlations between ChT in the temporal midperiphery and AL/SE suggest a role for the temporal choroid in axial elongation and myopia progression. These findings highlight the importance of considering peripheral ChT in understanding ocular growth and myopia management.

目的:本研究旨在调查成人近视眼脉络膜厚度(ChT)的分布,重点是黄斑、鼻中周和颞中周区域,并探讨其与轴长(AL)和屈光不正的关系:研究设计:横断面观察研究:方法:对 29 名成年志愿者的 29 只眼睛进行检查。使用高速扫源光学相干断层扫描测量了三个不同区域 50 度的 ChT:黄斑中心、鼻侧 33 度和颞侧 33 度。进行统计分析以评估不同区域之间 ChT 的差异以及与 AL 和球面等值(SE)的相关性:结果:发现黄斑区的 ChT 最厚,其次是鼻侧和颞侧中周区。在黄斑区和颞区,AL/SE 与 ChT 之间存在显著相关性,但在鼻区则没有。颞中周与 AL 和 SE 的相关性最强:这项研究揭示了近视眼ChT分布的鼻颞不对称现象,颞中周的ChT最薄。颞中周的ChT与AL/SE之间的强相关性表明,颞脉络膜在轴伸长和近视发展中起着重要作用。这些发现强调了在了解眼球生长和近视管理时考虑周边脉络膜厚度的重要性。
{"title":"Choroidal thickness in macular, nasal midperiphery, and temporal midperiphery regions and its relationship with axial length and refractive error.","authors":"Takahiro Hiraoka, Masato Tamura, Toshihiro Mino, Yoshikiyo Moriguchi, Masahiro Akiba, Yoshimi Sugiura, Toshifumi Mihashi, Tetsuro Oshika","doi":"10.1007/s10384-024-01128-5","DOIUrl":"10.1007/s10384-024-01128-5","url":null,"abstract":"<p><strong>Purpose: </strong>This study aimed to investigate the choroidal thickness (ChT) distribution in adult myopic eyes, focusing on the macular, nasal midperiphery, and temporal midperiphery regions, and to explore its relationship with axial length (AL) and refractive error.</p><p><strong>Study design: </strong>A cross-sectional, observational study.</p><p><strong>Methods: </strong>Twenty-nine eyes of 29 adult volunteers were examined. ChT was measured using high-speed swept-source optical coherence tomography covering an area of 50 degrees in three different regions: centered at macular, nasal side at 33 degrees, and temporal side at 33 degrees. Statistical analyses were performed to assess differences in ChT between regions and correlations with AL and spherical equivalent (SE).</p><p><strong>Results: </strong>ChT was found to be thickest in the macular region, followed by the nasal and temporal midperiphery regions. Significant correlations were observed between AL/SE and ChT in the macular and temporal regions, but not in the nasal region. The temporal midperiphery showed the strongest correlation with AL and SE.</p><p><strong>Conclusion: </strong>This study revealed a nasal-temporal asymmetry in ChT distribution in myopic eyes, with the temporal midperiphery showing the thinnest ChT. The strong correlations between ChT in the temporal midperiphery and AL/SE suggest a role for the temporal choroid in axial elongation and myopia progression. These findings highlight the importance of considering peripheral ChT in understanding ocular growth and myopia management.</p>","PeriodicalId":14563,"journal":{"name":"Japanese Journal of Ophthalmology","volume":" ","pages":"24-31"},"PeriodicalIF":2.1,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142564221","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Incidence of corneal perforation and lagophthalmos in patients with leprosy in Japan based on 40-year observations. 基于40年观察的日本麻风病患者角膜穿孔和眼lagophthalmmos的发生率
IF 2.1 3区 医学 Q2 OPHTHALMOLOGY Pub Date : 2025-01-01 Epub Date: 2025-01-03 DOI: 10.1007/s10384-024-01156-1
Takashi Ono, Takuya Iwasaki, Keita Takada, Shota Tokuda, Toshihiro Sakisaka, Yosai Mori, Ryohei Nejima, Masao Kakibuchi, Takashi Miyai, Kazunori Miyata

Purpose: This study aimed to report the incidence, characteristics, and prognosis of corneal perforation in patients with leprosy.

Study design: Retrospective observational study.

Methods: Patients who presented with leprosy and visited a specialised ophthalmology hospital (Miyata Eye Hospital, Miyazaki, Japan) between 1980 and 2020 were included. Their medical charts were retrospectively reviewed, and the incidence of lagophthalmos and corneal perforation was examined. Additionally, the presentation, treatment, and prognosis of patients with corneal perforations were assessed.

Results: In total, the records of 472 eyes of 236 patients (128 men and 108 women; mean age, 81.2 ± 7.5 years) diagnosed with leprosy were reviewed. Forty-one patients were diagnosed with lagophthalmos, and two of these patients (4.8%) showed signs of corneal perforation. Patients with lagophthalmos presented significantly more frequently with cicatricial contraction of eyelids (p < 0.001), superficial punctate keratopathy (p < 0.001), epithelial defect (p = 0.039), and corneal ulcer (p < 0.001) compared with patients without lagophthalmos. Patients with corneal perforation had uveitis more frequently compared with those without corneal perforation (p = 0.01).

Conclusion: Patients with leprosy frequently develop lagophthalmos. Patients with uveitis associated with leprosy are especially at risk of corneal perforation.

目的:本研究旨在报道麻风病患者角膜穿孔的发生率、特点和预后。研究设计:回顾性观察性研究。方法:纳入1980年至2020年间在专业眼科医院(Miyata Eye hospital, Miyazaki, Japan)就诊的麻风患者。我们回顾了他们的病历,并检查了眼lageyes和角膜穿孔的发生率。此外,我们还评估了角膜穿孔患者的表现、治疗和预后。结果:236例患者共472只眼(男128只,女108只;诊断为麻风病的平均年龄为81.2±7.5岁。41例患者被诊断为lagophthalmos,其中2例(4.8%)有角膜穿孔的迹象。结论:麻风病患者常发生眼lagophthalmmos。与麻风病相关的葡萄膜炎患者尤其有角膜穿孔的危险。
{"title":"Incidence of corneal perforation and lagophthalmos in patients with leprosy in Japan based on 40-year observations.","authors":"Takashi Ono, Takuya Iwasaki, Keita Takada, Shota Tokuda, Toshihiro Sakisaka, Yosai Mori, Ryohei Nejima, Masao Kakibuchi, Takashi Miyai, Kazunori Miyata","doi":"10.1007/s10384-024-01156-1","DOIUrl":"10.1007/s10384-024-01156-1","url":null,"abstract":"<p><strong>Purpose: </strong>This study aimed to report the incidence, characteristics, and prognosis of corneal perforation in patients with leprosy.</p><p><strong>Study design: </strong>Retrospective observational study.</p><p><strong>Methods: </strong>Patients who presented with leprosy and visited a specialised ophthalmology hospital (Miyata Eye Hospital, Miyazaki, Japan) between 1980 and 2020 were included. Their medical charts were retrospectively reviewed, and the incidence of lagophthalmos and corneal perforation was examined. Additionally, the presentation, treatment, and prognosis of patients with corneal perforations were assessed.</p><p><strong>Results: </strong>In total, the records of 472 eyes of 236 patients (128 men and 108 women; mean age, 81.2 ± 7.5 years) diagnosed with leprosy were reviewed. Forty-one patients were diagnosed with lagophthalmos, and two of these patients (4.8%) showed signs of corneal perforation. Patients with lagophthalmos presented significantly more frequently with cicatricial contraction of eyelids (p < 0.001), superficial punctate keratopathy (p < 0.001), epithelial defect (p = 0.039), and corneal ulcer (p < 0.001) compared with patients without lagophthalmos. Patients with corneal perforation had uveitis more frequently compared with those without corneal perforation (p = 0.01).</p><p><strong>Conclusion: </strong>Patients with leprosy frequently develop lagophthalmos. Patients with uveitis associated with leprosy are especially at risk of corneal perforation.</p>","PeriodicalId":14563,"journal":{"name":"Japanese Journal of Ophthalmology","volume":" ","pages":"152-158"},"PeriodicalIF":2.1,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142921679","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Three-year outcomes of surgical bleb revision with mitomycin C for early scarring bleb after trabeculectomy. 使用丝裂霉素 C 对小梁切除术后的早期瘢痕眼泡进行手术修补的三年疗效。
IF 2.1 3区 医学 Q2 OPHTHALMOLOGY Pub Date : 2025-01-01 Epub Date: 2024-11-21 DOI: 10.1007/s10384-024-01142-7
Risa Caraher-Masuda, Mari Sakamoto, Mina Okuda, Fumio Takano, Sotaro Mori, Kaori Ueda, Akiyasu Kanamori, Yuko Yamada-Nakanishi, Makoto Nakamura

Purpose: To report the 3-year outcomes of surgical bleb revision (SBR) with mitomycin C (MMC) for early scarring bleb after trabeculectomy (TLE).

Study design: Retrospective observational study.

Methods: We included glaucoma patients aged ≧ 18 who underwent SBR with MMC within 6 months of their first TLE at Kobe University Hospital and were followed for at least 6 months. The primary outcome measure was the three-year success rate of SBR. We defined surgical success as: intraocular pressure (IOP) reduction ≧ 20% from baseline and 5 ≦ IOP ≦ 18 mmHg. Failure was defined when the IOP deviated from the criteria, when the eye required additional glaucoma surgery, and when the eye lost light perception. Complete success (CS) was success without glaucoma medications and qualified success (QS) was success with glaucoma medications. The secondary outcome measures included IOP, the number of glaucoma medications, mean deviation (MD), best corrected visual acuity (BCVA), corneal endothelial cell density (ECD), and surgical complications.

Results: Sixty-eight eyes of 68 patients were analyzed. The median interval between initial TLE and SBR was 2 months. Overall success rate at three-year after SBR were 45.1% and 9.6% for QS and CS, respectively. A greater number of medications used before TLE was a contributing factor to failure (P = 0.02). 22 eyes (32.4%) underwent additional glaucoma surgery, and 41 eyes (60.3%) were spared from additional glaucoma surgery within 3 years after SBR. The median IOP decreased form 24.0 mmHg to 11.0 mmHg 3 years after SBR, and the number of medications decreased from 4 to 2 (P < 0.01). MD remained unchanged, but BCVA and ECD decreased at 3years postoperatively. There were no serious complications of SBR.

Conclusion: SBR may be an effective treatment option for early scarring blebs after TLE but is unsuccessful in eyes that have used many glaucoma medications prior to TLE.

目的:报告使用丝裂霉素C(MMC)对小梁切除术(TLE)后早期瘢痕形成的眼泡进行手术修整(SBR)的3年结果:研究设计:回顾性观察研究:我们纳入了在神户大学医院首次接受小梁切除术后6个月内接受SBR联合MMC治疗的年龄≧18岁的青光眼患者,并对其进行了至少6个月的随访。主要结果指标是 SBR 的三年成功率。我们将手术成功定义为:眼压(IOP)比基线降低≧ 20%,且 5 ≦ IOP ≦ 18 mmHg。当眼压偏离标准、眼睛需要进行额外的青光眼手术以及眼睛失去光感时,即定义为失败。完全成功(CS)是指未使用青光眼药物的成功,合格成功(QS)是指使用青光眼药物的成功。次要结果指标包括眼压、青光眼药物治疗次数、平均偏差(MD)、最佳矫正视力(BCVA)、角膜内皮细胞密度(ECD)和手术并发症:对 68 名患者的 68 只眼睛进行了分析。初次TLE与SBR之间的中位间隔为2个月。SBR术后三年,QS和CS的总体成功率分别为45.1%和9.6%。TLE前使用的药物较多是导致失败的一个因素(P = 0.02)。22只眼睛(32.4%)接受了额外的青光眼手术,41只眼睛(60.3%)在SBR术后3年内没有接受额外的青光眼手术。SBR 3 年后,眼压中位数从 24.0 mmHg 降至 11.0 mmHg,用药次数从 4 次降至 2 次(P < 0.01)。术后 3 年,MD 保持不变,但 BCVA 和 ECD 有所下降。SBR术后未出现严重并发症:结论:SBR可能是治疗TLE术后早期瘢痕性出血的有效方法,但对于TLE术前已使用过多种青光眼药物的眼睛来说并不成功。
{"title":"Three-year outcomes of surgical bleb revision with mitomycin C for early scarring bleb after trabeculectomy.","authors":"Risa Caraher-Masuda, Mari Sakamoto, Mina Okuda, Fumio Takano, Sotaro Mori, Kaori Ueda, Akiyasu Kanamori, Yuko Yamada-Nakanishi, Makoto Nakamura","doi":"10.1007/s10384-024-01142-7","DOIUrl":"10.1007/s10384-024-01142-7","url":null,"abstract":"<p><strong>Purpose: </strong>To report the 3-year outcomes of surgical bleb revision (SBR) with mitomycin C (MMC) for early scarring bleb after trabeculectomy (TLE).</p><p><strong>Study design: </strong>Retrospective observational study.</p><p><strong>Methods: </strong>We included glaucoma patients aged ≧ 18 who underwent SBR with MMC within 6 months of their first TLE at Kobe University Hospital and were followed for at least 6 months. The primary outcome measure was the three-year success rate of SBR. We defined surgical success as: intraocular pressure (IOP) reduction ≧ 20% from baseline and 5 ≦ IOP ≦ 18 mmHg. Failure was defined when the IOP deviated from the criteria, when the eye required additional glaucoma surgery, and when the eye lost light perception. Complete success (CS) was success without glaucoma medications and qualified success (QS) was success with glaucoma medications. The secondary outcome measures included IOP, the number of glaucoma medications, mean deviation (MD), best corrected visual acuity (BCVA), corneal endothelial cell density (ECD), and surgical complications.</p><p><strong>Results: </strong>Sixty-eight eyes of 68 patients were analyzed. The median interval between initial TLE and SBR was 2 months. Overall success rate at three-year after SBR were 45.1% and 9.6% for QS and CS, respectively. A greater number of medications used before TLE was a contributing factor to failure (P = 0.02). 22 eyes (32.4%) underwent additional glaucoma surgery, and 41 eyes (60.3%) were spared from additional glaucoma surgery within 3 years after SBR. The median IOP decreased form 24.0 mmHg to 11.0 mmHg 3 years after SBR, and the number of medications decreased from 4 to 2 (P < 0.01). MD remained unchanged, but BCVA and ECD decreased at 3years postoperatively. There were no serious complications of SBR.</p><p><strong>Conclusion: </strong>SBR may be an effective treatment option for early scarring blebs after TLE but is unsuccessful in eyes that have used many glaucoma medications prior to TLE.</p>","PeriodicalId":14563,"journal":{"name":"Japanese Journal of Ophthalmology","volume":" ","pages":"101-109"},"PeriodicalIF":2.1,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11821706/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142681813","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Usage status of biologics for the chronic treatment of optic neuritis in neuromyelitis optica spectrum disorders in Japan. 日本用于神经脊髓炎视谱系障碍视神经炎慢性治疗的生物制剂的使用状况。
IF 2.1 3区 医学 Q2 OPHTHALMOLOGY Pub Date : 2025-01-01 Epub Date: 2024-10-29 DOI: 10.1007/s10384-024-01129-4
Yohei Takahashi, Takeshi Kezuka, Keigo Shikishima, Akiko Yamagami, Hideki Chuman, Makoto Nakamura, Satoshi Ueki, Akiko Kimura, Masato Hashimoto, Sonoko Tatsui, Kimiyo Mashimo, Hitoshi Ishikawa

Purpose: To investigate the usage status of biologics for the chronic treatment of optic neuritis including neuromyelitis optica spectrum disorders in Japan.

Design: Multicenter retrospective case series.

Methods: Patients diagnosed with anti-aquaporin 4 antibody (AQP4-Ab) positive optic neuritis and had been initiated on biologics (satralizumab, eculizumab, and inebilizumab) between January 2020 and August 2022 were identified at 30 facilities in Japan. These patients were investigated regarding changes in oral steroid doses, optic neuritis relapse, and adverse events after initiation of biologics.

Results: Eighty-eight patients with AQP4-Ab positive optic neuritis initiated on biologics were included. Satralizumab was the most common biologic used (79 patients), followed by eculizumab (6 patients) and inebilizumab (3 patients). In the satralizumab group, during the observation period (10.0±7.0 months) until February 2023, the oral steroid dose was reduced significantly from 13.8 ± 8.6 mg/day at the time of initiation to 5.3 ± 4.8 mg/day (p < 0.001). No relapse of optic neuritis was observed in 76 of 79 patients (96.2%) after initiation of satralizumab. Furthermore, in 15 patients who succeeded in discontinuing steroids during 8.5 ± 5.8 months after initiation of satralizumab, no relapse of optic neuritis was observed throughout the observation period. Adverse events occurred in 7 patients with satralizumab and 2 patients with eculizumab, but no serious infections were observed.

Conclusions: Satralizumab was the most commonly used biologic for AQP4-Ab positive optic neuritis in Japan. This study demonstrates the efficacy and safety of satralizumab in preventing the relapse of optic neuritis.

目的:调查日本用于慢性视神经炎(包括视神经炎谱系障碍)治疗的生物制剂的使用情况:多中心回顾性病例系列:方法:在日本的 30 家医疗机构中,对 2020 年 1 月至 2022 年 8 月期间确诊为抗喹波素 4 抗体(AQP4-Ab)阳性视神经炎并开始使用生物制剂(沙妥珠单抗、依库珠单抗和伊奈珠单抗)的患者进行识别。对这些患者口服类固醇剂量的变化、视神经炎复发以及开始使用生物制剂后的不良反应进行了调查:结果:共纳入88名AQP4-Ab阳性视神经炎患者,他们开始使用生物制剂。萨妥珠单抗是最常用的生物制剂(79 例),其次是依库珠单抗(6 例)和伊奈珠单抗(3 例)。在观察期(10.0±7.0 个月)至 2023 年 2 月期间,萨妥珠单抗组的口服类固醇剂量从开始时的 13.8±8.6 毫克/天大幅减少至 5.3±4.8 毫克/天(p < 0.001)。79名患者中有76名(96.2%)在开始使用萨曲珠单抗后未发现视神经炎复发。此外,在开始使用萨曲珠单抗后 8.5 ± 5.8 个月内成功停用类固醇的 15 名患者中,在整个观察期间均未观察到视神经炎复发。7名使用沙特珠单抗的患者和2名使用依库珠单抗的患者出现了不良反应,但未观察到严重感染:结论:萨曲珠单抗是日本治疗 AQP4-Ab 阳性视神经炎最常用的生物制剂。这项研究证明了萨他珠单抗在预防视神经炎复发方面的有效性和安全性。
{"title":"Usage status of biologics for the chronic treatment of optic neuritis in neuromyelitis optica spectrum disorders in Japan.","authors":"Yohei Takahashi, Takeshi Kezuka, Keigo Shikishima, Akiko Yamagami, Hideki Chuman, Makoto Nakamura, Satoshi Ueki, Akiko Kimura, Masato Hashimoto, Sonoko Tatsui, Kimiyo Mashimo, Hitoshi Ishikawa","doi":"10.1007/s10384-024-01129-4","DOIUrl":"10.1007/s10384-024-01129-4","url":null,"abstract":"<p><strong>Purpose: </strong>To investigate the usage status of biologics for the chronic treatment of optic neuritis including neuromyelitis optica spectrum disorders in Japan.</p><p><strong>Design: </strong>Multicenter retrospective case series.</p><p><strong>Methods: </strong>Patients diagnosed with anti-aquaporin 4 antibody (AQP4-Ab) positive optic neuritis and had been initiated on biologics (satralizumab, eculizumab, and inebilizumab) between January 2020 and August 2022 were identified at 30 facilities in Japan. These patients were investigated regarding changes in oral steroid doses, optic neuritis relapse, and adverse events after initiation of biologics.</p><p><strong>Results: </strong>Eighty-eight patients with AQP4-Ab positive optic neuritis initiated on biologics were included. Satralizumab was the most common biologic used (79 patients), followed by eculizumab (6 patients) and inebilizumab (3 patients). In the satralizumab group, during the observation period (10.0±7.0 months) until February 2023, the oral steroid dose was reduced significantly from 13.8 ± 8.6 mg/day at the time of initiation to 5.3 ± 4.8 mg/day (p < 0.001). No relapse of optic neuritis was observed in 76 of 79 patients (96.2%) after initiation of satralizumab. Furthermore, in 15 patients who succeeded in discontinuing steroids during 8.5 ± 5.8 months after initiation of satralizumab, no relapse of optic neuritis was observed throughout the observation period. Adverse events occurred in 7 patients with satralizumab and 2 patients with eculizumab, but no serious infections were observed.</p><p><strong>Conclusions: </strong>Satralizumab was the most commonly used biologic for AQP4-Ab positive optic neuritis in Japan. This study demonstrates the efficacy and safety of satralizumab in preventing the relapse of optic neuritis.</p>","PeriodicalId":14563,"journal":{"name":"Japanese Journal of Ophthalmology","volume":" ","pages":"81-92"},"PeriodicalIF":2.1,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11821680/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142545467","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Scientific Reviewers. 科学评审员。
IF 2.1 3区 医学 Q2 OPHTHALMOLOGY Pub Date : 2024-11-21 DOI: 10.1007/s10384-024-01136-5
{"title":"Scientific Reviewers.","authors":"","doi":"10.1007/s10384-024-01136-5","DOIUrl":"https://doi.org/10.1007/s10384-024-01136-5","url":null,"abstract":"","PeriodicalId":14563,"journal":{"name":"Japanese Journal of Ophthalmology","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2024-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142681811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Visual prognostic factors following surgery for stage 3 idiopathic epiretinal membrane by Govetto classification. 根据 Govetto 分类法,特发性视网膜外膜 3 期手术后的视觉预后因素。
IF 2.1 3区 医学 Q2 OPHTHALMOLOGY Pub Date : 2024-11-01 Epub Date: 2024-08-31 DOI: 10.1007/s10384-024-01110-1
Takafumi Suzuki, Chisato Otaki, Yoshiki Ueta, Hideo Tate, Naoko Tachi, Masako Nagahara, Kunihiro Azuma, Takashi Ueta, Makoto Aihara

Purpose: To investigate the visual prognosis of metamorphopsia in patients undergoing surgery for stage 3 idiopathic epiretinal membrane (ERM) by Govetto classification using preoperative optical coherence tomography (OCT) parameters.

Study design: Retrospective clinical study.

Method: This study included 45 eyes of 45 patients with a minimum follow-up period of 3 months. The best-corrected visual acuity (BCVA) and metamorphopsia score using the M-CHARTS were recorded. Central foveal thickness (CFT), inner nuclear layer thickness (INL), ectopic inner retinal layer thickness (EIFL), outer retinal layer thickness, disruption of the ellipsoid zone, cotton ball sign, and intraretinal cystoid changes were measured based on spectral domain OCT. Preoperative and postoperative values and conditions were compared, and correlations between the preoperative values or conditions and postoperative metamorphopsia scores or BCVA were analyzed.

Results: After surgery, the horizontal, vertical, and mean metamorphopsia scores, as well as BCVA, CFT, INL, and EIFL significantly improved (p < 0.001). Using multivariate analysis, only preoperative CFT was a significant explanatory parameter for both the postoperative horizontal metamorphopsia scores and mean values of the postoperative horizontal and vertical metamorphopsia scores (p = 0.019 and p = 0.011, respectively). Age (p = 0.011) and preoperative CFT (p = 0.026) were significant explanatory parameters of postoperative BCVA.

Conclusion: Preoperative CFT significantly correlated with postoperative metamorphopsia in patients undergoing surgery for stage 3 idiopathic ERM. This finding might help surgeons predict postoperative visual outcomes and make timely surgical decisions.

目的:利用术前光学相干断层扫描(OCT)参数,按照戈韦托(Govetto)分类法,研究接受特发性视网膜外膜(ERM)3期手术患者的变形视觉预后:研究设计:回顾性临床研究:本研究包括 45 名患者的 45 只眼睛,随访期至少 3 个月。使用 M-CHARTS 记录最佳矫正视力(BCVA)和变形评分。根据光谱域 OCT 测量了中心眼窝厚度(CFT)、内核层厚度(INL)、异位视网膜内层厚度(EIFL)、视网膜外层厚度、椭圆形区破坏、棉球征和视网膜内囊样变。比较术前和术后的数值和情况,分析术前数值或情况与术后变形评分或 BCVA 之间的相关性:结果:术后,水平、垂直和平均变形评分,以及 BCVA、CFT、INL 和 EIFL 均明显改善(p 结论:术前 CFT 与术后 BCVA 显著相关:在接受特发性 ERM 3 期手术的患者中,术前 CFT 与术后变形明显相关。这一发现可能有助于外科医生预测术后视觉结果并及时做出手术决定。
{"title":"Visual prognostic factors following surgery for stage 3 idiopathic epiretinal membrane by Govetto classification.","authors":"Takafumi Suzuki, Chisato Otaki, Yoshiki Ueta, Hideo Tate, Naoko Tachi, Masako Nagahara, Kunihiro Azuma, Takashi Ueta, Makoto Aihara","doi":"10.1007/s10384-024-01110-1","DOIUrl":"10.1007/s10384-024-01110-1","url":null,"abstract":"<p><strong>Purpose: </strong>To investigate the visual prognosis of metamorphopsia in patients undergoing surgery for stage 3 idiopathic epiretinal membrane (ERM) by Govetto classification using preoperative optical coherence tomography (OCT) parameters.</p><p><strong>Study design: </strong>Retrospective clinical study.</p><p><strong>Method: </strong>This study included 45 eyes of 45 patients with a minimum follow-up period of 3 months. The best-corrected visual acuity (BCVA) and metamorphopsia score using the M-CHARTS were recorded. Central foveal thickness (CFT), inner nuclear layer thickness (INL), ectopic inner retinal layer thickness (EIFL), outer retinal layer thickness, disruption of the ellipsoid zone, cotton ball sign, and intraretinal cystoid changes were measured based on spectral domain OCT. Preoperative and postoperative values and conditions were compared, and correlations between the preoperative values or conditions and postoperative metamorphopsia scores or BCVA were analyzed.</p><p><strong>Results: </strong>After surgery, the horizontal, vertical, and mean metamorphopsia scores, as well as BCVA, CFT, INL, and EIFL significantly improved (p < 0.001). Using multivariate analysis, only preoperative CFT was a significant explanatory parameter for both the postoperative horizontal metamorphopsia scores and mean values of the postoperative horizontal and vertical metamorphopsia scores (p = 0.019 and p = 0.011, respectively). Age (p = 0.011) and preoperative CFT (p = 0.026) were significant explanatory parameters of postoperative BCVA.</p><p><strong>Conclusion: </strong>Preoperative CFT significantly correlated with postoperative metamorphopsia in patients undergoing surgery for stage 3 idiopathic ERM. This finding might help surgeons predict postoperative visual outcomes and make timely surgical decisions.</p>","PeriodicalId":14563,"journal":{"name":"Japanese Journal of Ophthalmology","volume":" ","pages":"621-627"},"PeriodicalIF":2.1,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142107442","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical features and multimodal imaging of primary choroidal lymphoma. 原发性脉络膜淋巴瘤的临床特征和多模式成像。
IF 2.1 3区 医学 Q2 OPHTHALMOLOGY Pub Date : 2024-11-01 Epub Date: 2024-09-28 DOI: 10.1007/s10384-024-01102-1
Hiroshi Goto, Kazuhiko Umazume, Yoshihiko Usui, Noriko Nishikawa

Purpose: To clarify the clinical features including multimodal imaging of primary choroidal lymphoma.

Study design: Retrospective, observational case series METHODS: Six consecutive patients with primary choroidal lymphoma diagnosed at Tokyo Medical University Hospital were studied. Demographic profile, clinical features and multimodal imaging were reviewed retrospectively.

Results: The patients comprised 3 men and 3 women with average age of 68.2 ± 12.4 years. Clinical diagnosis before referring to our hospital included Vogt-Koyanagi-Harada disease, posterior scleritis, and choroidal hemangioma, and no patients had been diagnosed with choroidal lymphoma. Average duration from onset of ocular symptoms to establishing a diagnosis was 14.2 months. Ocular fundus examination revealed yellowish orange nummular infiltration in all six cases, and granular pigment deposits at the posterior pole in four cases. Optical coherence tomography showed increased choroidal thickness and waving of the retinal pigment epithelium in all cases. Ultrasonography depicted choroidal thickening and extraocular nodular lesions adjacent to the posterior sclera in all cases. None of the cases showed elevated interleukin-10 in the aqueous humor. Ocular fundus manifestations and visual acuity improved after external beam radiation therapy, except one case with bullous retinal detachment from the initial visit.

Conclusions: Characteristic ocular fundus manifestation together with multimodal imaging findings are useful for the clinical diagnosis of primary choroidal lymphoma.

目的:阐明原发性脉络膜淋巴瘤的临床特征,包括多模态成像:方法:对东京医科大学附属医院连续确诊的六例原发性脉络膜淋巴瘤患者进行研究。结果:患者包括 3 名男性和 3 名女性:结果:患者中3男3女,平均年龄(68.2±12.4)岁。来我院就诊前的临床诊断包括Vogt-Koyanagi-Harada病、后巩膜炎和脉络膜血管瘤,没有患者被诊断为脉络膜淋巴瘤。从出现眼部症状到确诊的平均时间为 14.2 个月。眼底检查显示,所有六例患者均有黄橙色麻木性浸润,四例患者后极部有颗粒状色素沉积。光学相干断层扫描显示,所有病例的脉络膜厚度增加,视网膜色素上皮呈波浪状。超声波检查显示所有病例的脉络膜增厚,后巩膜附近出现眼外结节病变。所有病例的眼房水白细胞介素-10均未升高。外照射治疗后,眼底表现和视力均有所改善,只有一例患者在初诊时出现大泡性视网膜脱离:结论:特征性眼底表现和多模态成像结果有助于原发性脉络膜淋巴瘤的临床诊断。
{"title":"Clinical features and multimodal imaging of primary choroidal lymphoma.","authors":"Hiroshi Goto, Kazuhiko Umazume, Yoshihiko Usui, Noriko Nishikawa","doi":"10.1007/s10384-024-01102-1","DOIUrl":"10.1007/s10384-024-01102-1","url":null,"abstract":"<p><strong>Purpose: </strong>To clarify the clinical features including multimodal imaging of primary choroidal lymphoma.</p><p><strong>Study design: </strong>Retrospective, observational case series METHODS: Six consecutive patients with primary choroidal lymphoma diagnosed at Tokyo Medical University Hospital were studied. Demographic profile, clinical features and multimodal imaging were reviewed retrospectively.</p><p><strong>Results: </strong>The patients comprised 3 men and 3 women with average age of 68.2 ± 12.4 years. Clinical diagnosis before referring to our hospital included Vogt-Koyanagi-Harada disease, posterior scleritis, and choroidal hemangioma, and no patients had been diagnosed with choroidal lymphoma. Average duration from onset of ocular symptoms to establishing a diagnosis was 14.2 months. Ocular fundus examination revealed yellowish orange nummular infiltration in all six cases, and granular pigment deposits at the posterior pole in four cases. Optical coherence tomography showed increased choroidal thickness and waving of the retinal pigment epithelium in all cases. Ultrasonography depicted choroidal thickening and extraocular nodular lesions adjacent to the posterior sclera in all cases. None of the cases showed elevated interleukin-10 in the aqueous humor. Ocular fundus manifestations and visual acuity improved after external beam radiation therapy, except one case with bullous retinal detachment from the initial visit.</p><p><strong>Conclusions: </strong>Characteristic ocular fundus manifestation together with multimodal imaging findings are useful for the clinical diagnosis of primary choroidal lymphoma.</p>","PeriodicalId":14563,"journal":{"name":"Japanese Journal of Ophthalmology","volume":" ","pages":"722-730"},"PeriodicalIF":2.1,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142346822","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Japanese Journal of Ophthalmology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1